UK markets open in 2 hours 45 minutes
  • NIKKEI 225

    28,705.87
    -158.45 (-0.55%)
     
  • HANG SENG

    28,695.13
    -403.16 (-1.39%)
     
  • CRUDE OIL

    67.46
    +1.37 (+2.07%)
     
  • GOLD FUTURES

    1,704.90
    +6.40 (+0.38%)
     
  • DOW

    31,496.30
    +572.20 (+1.85%)
     
  • BTC-GBP

    36,533.84
    +455.81 (+1.26%)
     
  • CMC Crypto 200

    1,024.21
    +81.03 (+8.59%)
     
  • ^IXIC

    12,920.15
    +196.65 (+1.55%)
     
  • ^FTAS

    3,771.73
    -20.36 (-0.54%)
     

Global Life Science Software Industry

ReportLinker
·11-min read

Global Life Science Software Market to Reach $8. 5 Billion by 2027. Amid the COVID-19 crisis, the global market for Life Science Software estimated at US$5. 5 Billion in the year 2020, is projected to reach a revised size of US$8.

New York, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Life Science Software Industry" - https://www.reportlinker.com/p05957252/?utm_source=GNW
5 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Cloud-based, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$5.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Premise segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.2% CAGR

The Life Science Software market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.We bring years of research experience to this 8th edition of our report. The 163-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • ArisGlobal LLC

  • Ducen IT

  • DXC Technology

  • EPAM Systems, Inc.

  • Fujitsu Ltd.

  • GE Healthcare

  • HCL Technologies Ltd.

  • Instem Group of Companies

  • Medidata Solutions, Inc.

  • Oracle Corporation

  • PDS

  • SAP SE

  • SAS Institute, Inc.

  • Signiant, Inc.

  • Veeva Systems, Inc.

  • Xybion Corporation




Read the full report: https://www.reportlinker.com/p05957252/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Life Science Software Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Life Science Software Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Life Science Software Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Life Science Software Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Cloud-based (Segment) World Market by Region/Country
in US$ Million: 2020 to 2027

Table 5: Cloud-based (Segment) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Cloud-based (Segment) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: On-Premise (Segment) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: On-Premise (Segment) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019

Table 9: On-Premise (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Pharmaceutical (End-Use) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027

Table 11: Pharmaceutical (End-Use) Retrospective Demand
Analysis in US$ Million by Region/Country: 2012-2019

Table 12: Pharmaceutical (End-Use) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 13: Biotechnology (End-Use) Demand Potential Worldwide in
US$ Million by Region/Country: 2020-2027

Table 14: Biotechnology (End-Use) Historic Sales Analysis in
US$ Million by Region/Country: 2012-2019

Table 15: Biotechnology (End-Use) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027

Table 16: Other End-Uses (End-Use) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027

Table 17: Other End-Uses (End-Use) Global Historic Analysis in
US$ Million by Region/Country: 2012-2019

Table 18: Other End-Uses (End-Use) Distribution of Global Sales
by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Life Science Software Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 19: United States Life Science Software Market Estimates
and Projections in US$ Million by Segment: 2020 to 2027

Table 20: Life Science Software Market in the United States by
Segment: A Historic Review in US$ Million for 2012-2019

Table 21: United States Life Science Software Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027

Table 22: United States Life Science Software Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 23: Life Science Software Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019

Table 24: Life Science Software Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 25: Canadian Life Science Software Market Estimates and
Forecasts in US$ Million by Segment: 2020 to 2027

Table 26: Canadian Life Science Software Historic Market Review
by Segment in US$ Million: 2012-2019

Table 27: Life Science Software Market in Canada: Percentage
Share Breakdown of Sales by Segment for 2012, 2020, and 2027

Table 28: Canadian Life Science Software Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 29: Life Science Software Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019

Table 30: Canadian Life Science Software Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 31: Japanese Market for Life Science Software: Annual
Sales Estimates and Projections in US$ Million by Segment for
the Period 2020-2027

Table 32: Life Science Software Market in Japan: Historic Sales
Analysis in US$ Million by Segment for the Period 2012-2019

Table 33: Japanese Life Science Software Market Share Analysis
by Segment: 2012 VS 2020 VS 2027

Table 34: Japanese Demand Estimates and Forecasts for Life
Science Software in US$ Million by End-Use: 2020 to 2027

Table 35: Japanese Life Science Software Market in US$ Million
by End-Use: 2012-2019

Table 36: Life Science Software Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027

CHINA
Table 37: Chinese Life Science Software Market Growth Prospects
in US$ Million by Segment for the Period 2020-2027

Table 38: Life Science Software Historic Market Analysis in
China in US$ Million by Segment: 2012-2019

Table 39: Chinese Life Science Software Market by Segment:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 40: Chinese Demand for Life Science Software in US$
Million by End-Use: 2020 to 2027

Table 41: Life Science Software Market Review in China in US$
Million by End-Use: 2012-2019

Table 42: Chinese Life Science Software Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Life Science Software Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 43: European Life Science Software Market Demand Scenario
in US$ Million by Region/Country: 2020-2027

Table 44: Life Science Software Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 45: European Life Science Software Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 46: European Life Science Software Market Estimates and
Forecasts in US$ Million by Segment: 2020-2027

Table 47: Life Science Software Market in Europe in US$ Million
by Segment: A Historic Review for the Period 2012-2019

Table 48: European Life Science Software Market Share Breakdown
by Segment: 2012 VS 2020 VS 2027

Table 49: European Life Science Software Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 50: Life Science Software Market in Europe: Summarization
of Historic Demand in US$ Million by End-Use for the Period
2012-2019

Table 51: European Life Science Software Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 52: Life Science Software Market in France by Segment:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 53: French Life Science Software Historic Market Scenario
in US$ Million by Segment: 2012-2019

Table 54: French Life Science Software Market Share Analysis by
Segment: 2012 VS 2020 VS 2027

Table 55: Life Science Software Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027

Table 56: French Life Science Software Historic Market Review
in US$ Million by End-Use: 2012-2019

Table 57: French Life Science Software Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY
Table 58: Life Science Software Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Segment for the
Period 2020-2027

Table 59: German Life Science Software Historic Market Analysis
in US$ Million by Segment: 2012-2019

Table 60: German Life Science Software Market Share Breakdown
by Segment: 2012 VS 2020 VS 2027

Table 61: Life Science Software Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 62: German Life Science Software Market in Retrospect in
US$ Million by End-Use: 2012-2019

Table 63: Life Science Software Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 64: Italian Life Science Software Market Growth Prospects
in US$ Million by Segment for the Period 2020-2027

Table 65: Life Science Software Historic Market Analysis in
Italy in US$ Million by Segment: 2012-2019

Table 66: Italian Life Science Software Market by Segment:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 67: Italian Demand for Life Science Software in US$
Million by End-Use: 2020 to 2027

Table 68: Life Science Software Market Review in Italy in US$
Million by End-Use: 2012-2019

Table 69: Italian Life Science Software Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 70: United Kingdom Market for Life Science Software:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2020-2027

Table 71: Life Science Software Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Segment for the
Period 2012-2019

Table 72: United Kingdom Life Science Software Market Share
Analysis by Segment: 2012 VS 2020 VS 2027

Table 73: United Kingdom Demand Estimates and Forecasts for
Life Science Software in US$ Million by End-Use: 2020 to 2027

Table 74: United Kingdom Life Science Software Market in US$
Million by End-Use: 2012-2019

Table 75: Life Science Software Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 76: Rest of Europe Life Science Software Market Estimates
and Forecasts in US$ Million by Segment: 2020-2027

Table 77: Life Science Software Market in Rest of Europe in US$
Million by Segment: A Historic Review for the Period 2012-2019

Table 78: Rest of Europe Life Science Software Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027

Table 79: Rest of Europe Life Science Software Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 80: Life Science Software Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 81: Rest of Europe Life Science Software Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 82: Life Science Software Market in Asia-Pacific by
Segment: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 83: Asia-Pacific Life Science Software Historic Market
Scenario in US$ Million by Segment: 2012-2019

Table 84: Asia-Pacific Life Science Software Market Share
Analysis by Segment: 2012 VS 2020 VS 2027

Table 85: Life Science Software Quantitative Demand Analysis in
Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 86: Asia-Pacific Life Science Software Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 87: Asia-Pacific Life Science Software Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

REST OF WORLD
Table 88: Rest of World Life Science Software Market Estimates
and Forecasts in US$ Million by Segment: 2020 to 2027

Table 89: Rest of World Life Science Software Historic Market
Review by Segment in US$ Million: 2012-2019

Table 90: Life Science Software Market in Rest of World:
Percentage Share Breakdown of Sales by Segment for 2012, 2020,
and 2027

Table 91: Rest of World Life Science Software Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 92: Life Science Software Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 93: Rest of World Life Science Software Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 31
Read the full report: https://www.reportlinker.com/p05957252/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001